Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516320 · ClinicalTrials.gov registry record · NA
Mechanisms of Diabetes Relapse After Bariatric Surgery
A NA study, sponsored by Blandine Laferrere.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01516320: Completed NA study, sponsored by Blandine Laferrere.
NCT01516320 is a NA study that has completed, run by Blandine Laferrere. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01516320, a NA study, has completed, sponsored by Blandine Laferrere.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the different mechanisms by which Gastric Bypass (GBP), laparoscopic adjustable gastric banding (LAGB) and vertical sleeve gastrectomy (VSG) affect glucose control. We wish to understand the role of weight loss versus changes in gut peptides in the short and long term in morbidly obese patients with Type 2 Diabetes Mellitus after GBP, LAGB or VSG. The 2 surgical groups will be compared at 10% equivalent weight loss and at after surgery in terms of gut hormones levels, insulin secretion and glucose control.
Primary Outcome
The investigators will assess insulin secretion in response to oral and intravenous nutrient and hormonal stimuli in the three groups.
Interventions
- PROCEDURE Roux-en-Y Gastric Bypass
- PROCEDURE Vertical Sleeve Gastrectomy
- PROCEDURE Laparoscopic adjustable gastric banding
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2009-05-13 |
| Est. Completion | 2014-09-01 |
| Phase | NA |
What the finished NCT01516320 record still lists
NCT01516320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Roux-en-Y Gastric Bypass is the first listed.
NCT01516320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01516320 about?
NCT01516320 is a clinical study titled "Mechanisms of Diabetes Relapse After Bariatric Surgery". The objective of this study is to investigate the different mechanisms by which Gastric Bypass (GBP), laparoscopic adjustable gastric banding (LAGB) and vertical sleeve gastrectomy (VSG) affect glucose control. We wish to understand the role of weight loss versus changes in gut peptides in the short...
What is the current status of trial NCT01516320?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2009-05-13. Estimated completion is 2014-09-01.
What interventions are being tested in trial NCT01516320?
The interventions under investigation include: Roux-en-Y Gastric Bypass (PROCEDURE), Vertical Sleeve Gastrectomy (PROCEDURE), Laparoscopic adjustable gastric banding (PROCEDURE).
Who is sponsoring clinical trial NCT01516320?
This trial is sponsored by Blandine Laferrere, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01516320's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI